BALVERSA® (erdafitinib)
- Interactive ingredient checker
- Pivotal clinical trial publications
- Search medical information
- U.S. FDA grants full approval for BALVERSA® to treat locally advanced or metastatic bladder cancer with select genetic alterations
- Useful links